Bausch Health Boosts Ad Spending For Expanding Supplement Lineup
This article was originally published in The Rose Sheet
Executive Summary
Canadian firm, recently renamed from Valeant Pharmaceuticals International, includes launches of Ocuvite Blue Light and PreserVision AREDS 2 Formula Chewable vitamins among its reasons for increasing its consumer health advertising spending. Q2 revenues for its consumer health segment were up 5% organically to $369m.